Inotrem is an advanced clinical stage biotech company specialized in immunotherapy to control dysregulated inflammatory reactions. The company proposes a new concept of controlling innate immunity that targets the TREM-1 pathway, an innate immune amplifier, balanced response in inflammatory diseases. En savoir plus
